Suppr超能文献

Burden of Obesity in Adults at a Tertiary Care Hospital.

作者信息

Bukasa Kakamba John, Wadhwani Shruti, Ntambue Malu Esperant, Wadhwani Nikita, Latil-Plat Françoise, Poka Nickson, Kapinga Kalambayi Isis, Bukasa Mutombo Manasse, Mohamed Abdifitah, Bangolo Ayrton I, M'buyamba Jean René

机构信息

Endocrinology, Metabolism, and Nuclear Medicine, Kinshasa University Clinics, Kinshasa, COD.

Endocrinology, Liège University Hospital Center, Liège, BEL.

出版信息

Cureus. 2025 May 25;17(5):e84776. doi: 10.7759/cureus.84776. eCollection 2025 May.

Abstract

BACKGROUND

Obesity is a well-established risk factor for many diseases, including hypertension, diabetes mellitus (DM), cardiovascular disease, and obstructive sleep apnea (OSA). Understanding the prevalence, demographics, and associated complications of obesity at the institutional level is crucial for tailoring effective preventive measures and treatment strategies.

OBJECTIVE

This study aims to investigate the epidemiology and complications of obesity among patients at the Avignon Hospital.

METHODS

This is a retrospective study of patients who consulted the Endocrinology Department at the Avignon Hospital for various endocrine disorders between January 2024 and April 2024. The sociodemographic, clinical, and biochemical variables were collected from both the obese and non-obese cohorts. The chi-square test was used to assess statistically significant associations between obesity and other covariates. Logistic regression analysis was used to determine the risk factors for ischemic heart disease in obese patients.

RESULTS

Among the 240 participants in the study, 54.2% were obese. Obesity was more prevalent among females (57.5%) when compared to males (50.4%), and in individuals aged greater than 60 years (68.8%) as compared to other age groups. Among obese patients, 39.2% had type 1, and 32.3% had type 2 diabetes. Obesity was prevalent in 76.4% of all patients with type 2 diabetes. Hypertension and coronary artery disease were present in 52.3% and 58.4% of all obese patients, respectively. OSA was found in 57.7% of obese patients. Among patients with mild, moderate, and severe sleep apnea, 79.5%, 82%, and 85% were obese, respectively. All patients (n = 16) with a fibrosis-4 index (FIB-4) score > 2.67 and 62% of patients with an indeterminate score between 1.3 and 2.67 were obese. Obesity was noted among 83.3% of chronic kidney disease patients and 66.7% of patients with hypertriglyceridemia. Logistic regression analyses revealed that DM and older age were predictive of ischemic heart disease in obese patients.

CONCLUSION

The majority of our study cohort consisted of obese patients. Obesity was highly prevalent among patients with DM, OSA, metabolic steatohepatitis-related fibrosis, and chronic kidney disease. Older age, DM, chronic kidney disease, and OSA were associated with a greater risk for ischemic heart disease in obese patients.

摘要

相似文献

1
Burden of Obesity in Adults at a Tertiary Care Hospital.
Cureus. 2025 May 25;17(5):e84776. doi: 10.7759/cureus.84776. eCollection 2025 May.
2
Sertindole for schizophrenia.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Home treatment for mental health problems: a systematic review.
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Systematic review on urine albumin testing for early detection of diabetic complications.
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
10
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.

本文引用的文献

1
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.
N Engl J Med. 2024 Oct 31;391(17):1573-1583. doi: 10.1056/NEJMoa2403664.
2
Obesity in adults.
Lancet. 2024 Sep 7;404(10456):972-987. doi: 10.1016/S0140-6736(24)01210-8. Epub 2024 Aug 16.
3
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
N Engl J Med. 2024 Jul 25;391(4):299-310. doi: 10.1056/NEJMoa2401943. Epub 2024 Jun 8.
4
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
N Engl J Med. 2024 Jul 25;391(4):311-319. doi: 10.1056/NEJMoa2401755. Epub 2024 Jun 7.
5
Obesity and chronic kidney disease.
Am J Physiol Endocrinol Metab. 2023 Jan 1;324(1):E24-E41. doi: 10.1152/ajpendo.00179.2022. Epub 2022 Nov 16.
6
Non-Communicable Diseases: The Invisible Epidemic.
J Clin Med. 2022 Oct 8;11(19):5939. doi: 10.3390/jcm11195939.
7
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
N Engl J Med. 2021 Mar 25;384(12):1113-1124. doi: 10.1056/NEJMoa2028395. Epub 2020 Nov 13.
8
Inverse Association Between Serum Vitamin B12 Concentration and Obesity Among Adults in the United States.
Front Endocrinol (Lausanne). 2019 Jun 27;10:414. doi: 10.3389/fendo.2019.00414. eCollection 2019.
9
Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over.
Curr Obes Rep. 2017 Jun;6(2):187-194. doi: 10.1007/s13679-017-0262-y.
10
Obesity and Subtypes of Incident Cardiovascular Disease.
J Am Heart Assoc. 2016 Jul 28;5(8):e003921. doi: 10.1161/JAHA.116.003921.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验